Stockscreener 앱 받기
0.00
100.00%
-79.97
전일 마감가:
$79.97
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$4.67B
수익:
$574.50M
순이익/손실:
$-78.58M
주가수익비율:
0.00
EPS:
-1.35
순현금흐름:
$1.58M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$79.99
Inari Medical Inc Stock (NARI) Company Profile
명칭
Inari Medical Inc
전화
949-923-4747
주소
6001 OAK CANYON, SUITE 100, IRVINE, CA
NARI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
0.00 | 4.67B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-09-18 | 개시 | Stifel | Hold |
| 2024-09-03 | 개시 | Leerink Partners | Market Perform |
| 2024-08-09 | 개시 | Deutsche Bank | Buy |
| 2024-07-25 | 개시 | William Blair | Outperform |
| 2024-07-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-23 | 개시 | Needham | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-09-29 | 개시 | Berenberg | Buy |
| 2022-09-13 | 개시 | Truist | Hold |
| 2022-06-21 | 개시 | Piper Sandler | Overweight |
| 2022-03-23 | 재개 | BofA Securities | Buy |
| 2020-12-15 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-11-18 | 개시 | BTIG Research | Buy |
| 2020-10-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-09-28 | 개시 | SVB Leerink | Outperform |
| 2020-06-19 | 개시 | Canaccord Genuity | Buy |
| 2020-06-16 | 개시 | BofA/Merrill | Neutral |
| 2020-06-16 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Inari Medical Inc 주식(NARI)의 최신 뉴스
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - ACCESS Newswire
Did Inari Medical, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateNARI - ACCESS Newswire
Shareholders that lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – NARI - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationNARI - ACCESS Newswire
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your RightsNARI - ACCESS Newswire
Class Action Filed Against Inari Medical, Inc. (NARI) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
An Investigation Has Commenced on Behalf of Inari Medical, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NARI Losses - ACCESS Newswire
Inari Medical, Inc. (NARI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky, LLP Investigates - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Inari Medical Inc (NARI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
0.22%
자본화:
|
볼륨(24시간):